337 related articles for article (PubMed ID: 38672182)
1. Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights.
Kaur G; Roy B
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672182
[TBL] [Abstract][Full Text] [Related]
2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
4. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
5. [Tumor angiogenesis: new approaches to cancer therapy].
Marmé D
Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.
Battegay EJ
J Mol Med (Berl); 1995 Jul; 73(7):333-46. PubMed ID: 8520966
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Progenitors in the Tumor Microenvironment.
Testa U; Pelosi E; Castelli G
Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
[TBL] [Abstract][Full Text] [Related]
8. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
9. The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
Leong A; Kim M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217955
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cells-directed angiogenesis in colorectal cancer: Interleukin as the mediator and pharmacological target.
Cui G; Liu H; Laugsand JB
Int Immunopharmacol; 2023 Jan; 114():109525. PubMed ID: 36508917
[TBL] [Abstract][Full Text] [Related]
11. Role of angiogenesis in tumor growth and metastasis.
Folkman J
Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
[TBL] [Abstract][Full Text] [Related]
12. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
13. Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.
Groblewska M; Mroczko B
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200145
[TBL] [Abstract][Full Text] [Related]
14. Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.
Bousseau S; Marchand M; Soleti R; Vergori L; Hilairet G; Recoquillon S; Le Mao M; Gueguen N; Khiati S; Clarion L; Bakalara N; Martinez MC; Germain S; Lenaers G; Andriantsitohaina R
FASEB J; 2019 May; 33(5):5864-5875. PubMed ID: 30817178
[TBL] [Abstract][Full Text] [Related]
15. Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses.
Xian D; Song J; Yang L; Xiong X; Lai R; Zhong J
Oxid Med Cell Longev; 2019; 2019():2304018. PubMed ID: 31178954
[TBL] [Abstract][Full Text] [Related]
16. AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review).
Salinas-Vera YM; Marchat LA; Gallardo-Rincón D; Ruiz-García E; Astudillo-De La Vega H; Echavarría-Zepeda R; López-Camarillo C
Int J Mol Med; 2019 Feb; 43(2):657-670. PubMed ID: 30483765
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches.
van Moorselaar RJ; Voest EE
Mol Cell Endocrinol; 2002 Nov; 197(1-2):239-50. PubMed ID: 12431818
[TBL] [Abstract][Full Text] [Related]
18. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]